Cite
MLA Citation
Yalin Tu et al.. “IDDF2022-ABS-0103 A selective class I HDAC inhibitor recovers intratumoral interferon signaling to overcome immune-checkpoint blockade resistance in hepatocellular carcinoma.” Gut, vol. 71, n.d., p. A18. http://access.bl.uk/ark:/81055/vdc_100163576071.0x000064